HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Bohumil Bednar Selected Research
Bohumil Bednar Research Topics
Disease
4
Neoplasms (Cancer)
06/2015 - 08/2007
3
Inflammation (Inflammations)
01/2017 - 01/2012
3
Hyperalgesia
07/2007 - 02/2003
2
Vascular System Injuries
01/2017 - 01/2015
2
Pain (Aches)
07/2007 - 02/2003
1
Vascular Remodeling
01/2017
1
Melanoma (Melanoma, Malignant)
06/2015
1
Neoplasm Metastasis (Metastasis)
06/2015
1
Weight Loss (Weight Reduction)
06/2015
1
Infections
01/2015
1
Chlamydia Infections
01/2015
1
Type 2 Diabetes Mellitus (MODY)
01/2014
1
Hypertension (High Blood Pressure)
08/2012
1
Atherosclerosis
01/2012
Drug/Important Bio-Agent (IBA)
5
Biomarkers (Surrogate Marker)
IBA
01/2017 - 01/2012
3
Peptide Hydrolases (Proteases)
FDA Link
01/2017 - 10/2010
3
Integrins
IBA
06/2015 - 10/2010
3
Carrageenan
IBA
07/2007 - 02/2003
2
Luciferases
IBA
06/2015 - 08/2007
2
Cathepsins
IBA
01/2012 - 10/2010
1
Metalloproteases (Metalloproteinases)
IBA
01/2017
1
Lipocalin-2
IBA
01/2017
1
Matrix Metalloproteinases (MMPs)
IBA
01/2017
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
06/2015
1
3- (6- methoxypyridin- 3- yl)- 3- (2- oxo- 3- (3- (5,6,7,8- tetrahydro(1,8)naphthyridin- 2- yl)propyl)imidazolidin- 1- yl)propionic acid
IBA
06/2015
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2015
1
Leukocyte Elastase (Neutrophil Elastase)
IBA
01/2015
1
Insulin (Novolin)
FDA Link
01/2014
1
Hemoglobins (Hemoglobin)
IBA
01/2013
1
Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
IBA
08/2012
1
Angiotensinogen
IBA
08/2012
1
Angiotensin I
IBA
08/2012
1
Enzymes
IBA
08/2012
1
Renin
IBA
08/2012
1
Ezetimibe (Zetia)
FDA Link
01/2012
1
Apolipoproteins E (ApoE)
IBA
01/2012
1
Vitronectin
IBA
10/2010
1
Tumor Biomarkers (Tumor Markers)
IBA
10/2010
1
Coloring Agents (Dyes)
IBA
10/2010
1
Peptidomimetics
IBA
10/2010
1
Irinotecan (Camptosar)
FDA Link
Generic
08/2007
1
Docetaxel (Taxotere)
FDA Link
08/2007
1
benzimidazole
IBA
04/2004
Therapy/Procedure
2
Therapeutics
01/2015 - 01/2012